Skip to content
Insider tapeFilings through Fri, Oct 9
Watchlist

Daniel R. Chevallard

CFO at LENZ Therapeutics, Inc. (LENZ)

Purchase track record

Below average. Based on 2 purchases with a full 90 days of price history.

5
Avg. 90-day return-34.9%
vs. S&P 500-44.3%
Beat the market0%
Paper profit on buys−$79K
Total bought / sold$114K / $0

Reported trades

Filed Stock Type Shares Price Value Since
Mar 30SEC LENZLENZ Therapeutics, Inc. Buy 7,50012,886 held (+139%) $8.57 $64K -57.5%
Nov 7SEC LENZLENZ Therapeutics, Inc. Buy 203,208 held (+1%) $22.71 $454 -83.9%
Nov 7SEC LENZLENZ Therapeutics, Inc. Buy 2,1785,386 held (+68%) $22.76 $50K -84.0%
  • Buy

    CFO Daniel R. Chevallard bought $64K of LENZ at $8.57 — largest purchase by this insider in our records; raises the stake by 139%.

  • Buy

    CFO Daniel R. Chevallard bought $454 of LENZ at $22.71 — first open-market purchase in our records.

  • Buy

    CFO Daniel R. Chevallard bought $50K of LENZ at $22.76 — largest purchase by this insider in our records; raises the stake by 68%.